Clinical Trials Logo

Clinical Trial Summary

Description: Capsaicin (8- methyl-N-vanillyl-6-nonenamide) has been demonstrated to have a therapeutic effect in idiopathic rhinitis. We hypothesize that capsaicin has a therapeutic effect on rhinogenic headaches, in addition to the previously studied decongestive effects. This study aims to evaluate capsaicin impact on headaches attributed to V1, V2 distribution of the sinonasal cavity. This study is a randomized, double-blinded, parallel trial.


Clinical Trial Description

1. Title: The role of capsaicin in treatment of rhinogenic headache 2. Description: Capsaicin (8- methyl-N-vanillyl-6-nonenamide) has been demonstrated to have a therapeutic effect in idiopathic rhinitis, migraines and cluster headaches. We hypothesize that capsaicin has a therapeutic effect on rhinogenic headaches as well. This study aims to evaluate capsaicin impact on headaches attributed to the nose and paranasal sinus distribution. 3. Interventions, evaluations, and follow-up: Subjects are recruited from an Otolaryngology clinic, where a formal headache questionnaire is administered in-office, and standard endoscopy is performed in office to rule out confounding causes of headache and sinonasal disease. Written instructions are provided and consent obtained. A symptom journal is provided. Subjects are randomly selected to receive two bottles of either eucalyptol spray (placebo) or sinus buster (capsaicin) spray and are blinded to the content of the spray bottle. They are instructed to use the nasal spray one to two times daily. Subjects are permitted to continue to take headache medication as needed, but it must be recorded in their symptom journal. The journal is completed daily, and includes medication use, a headache pain score, and side effect log. Additionally, subjects fill out SinoNasal Outcome test (SNOT)22 at 2 weeks, 4 weeks, and 8 weeks. Weekly emails are sent to remind subject to fill out their journal. A phone call is made to the subject to survey them on progress at 2 and 6 weeks. Follow up visits are scheduled at 4 weeks and 8 weeks, or sooner if problems arise. A standard nasal endoscopy is performed at the first and last visit. 4. Additional data that would be tracked: Quality of life score as measured by SNOT-22 scores, treatment failure and drop-outs, and objective changes in sinus endoscopy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03330639
Study type Interventional
Source University of Nebraska
Contact
Status Withdrawn
Phase N/A
Start date July 2017
Completion date June 23, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03632928 - Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
Completed NCT00246350 - Spinal Manipulation for Treatment of Chronic Headaches Phase 2
Completed NCT05404113 - Sustained Natural Apophyseal Glide and Deep Friction Massage in Patients With Cervicogenic Headache N/A
Recruiting NCT03416114 - RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres N/A
Enrolling by invitation NCT04976985 - Osteopathic Manipulative Treatment and Migraine Headaches N/A
Completed NCT05153876 - An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Recruiting NCT06041997 - Smartphone Use Restriction as Treatment of Primary Headache N/A
Active, not recruiting NCT04936321 - Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial N/A
Completed NCT04220580 - Multiomics After Cold Pressor Test of People Who Are Unable to Have Headache N/A
Completed NCT03385174 - Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brain's Vessels and Blood Flow N/A
Completed NCT03137147 - Intervention for Sleep and Pain in Youth N/A
Completed NCT02910921 - Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit
Recruiting NCT05619354 - Validity and Reliability of the Dutch HDI
Recruiting NCT06206772 - Resting State Functional Connectivity in Cluster Headache
Terminated NCT02624661 - Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique Phase 1/Phase 2
Completed NCT02662972 - Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. Phase 1/Phase 2
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Completed NCT04891848 - Assessment of Inflammation in Primary Headaches
Recruiting NCT04715685 - Mind Body Balance for Pediatric Migraine N/A
Completed NCT00457496 - Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in Working Communities Phase 3